CHD3_HUMAN - dbPTM
CHD3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CHD3_HUMAN
UniProt AC Q12873
Protein Name Chromodomain-helicase-DNA-binding protein 3
Gene Name CHD3
Organism Homo sapiens (Human).
Sequence Length 2000
Subcellular Localization Nucleus . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Associates with centrosomes in interphase and mitosis.
Protein Description Component of the histone deacetylase NuRD complex which participates in the remodeling of chromatin by deacetylating histones. Required for anchoring centrosomal pericentrin in both interphase and mitosis, for spindle organization and centrosome integrity..
Protein Sequence MKAADTVILWARSKNDQLRISFPPGLCWGDRMPDKDDIRLLPSALGVKKRKRGPKKQKENKPGKPRKRKKRDSEEEFGSERDEYREKSESGGSEYGTGPGRKRRRKHREKKEKKTKRRKKGEGDGGQKQVEQKSSATLLLTWGLEDVEHVFSEEDYHTLTNYKAFSQFMRPLIAKKNPKIPMSKMMTILGAKWREFSANNPFKGSAAAVAAAAAAAAAAVAEQVSAAVSSATPIAPSGPPALPPPPAADIQPPPIRRAKTKEGKGPGHKRRSKSPRVPDGRKKLRGKKMAPLKIKLGLLGGKRKKGGSYVFQSDEGPEPEAEESDLDSGSVHSASGRPDGPVRTKKLKRGRPGRKKKKVLGCPAVAGEEEVDGYETDHQDYCEVCQQGGEIILCDTCPRAYHLVCLDPELDRAPEGKWSCPHCEKEGVQWEAKEEEEEYEEEGEEEGEKEEEDDHMEYCRVCKDGGELLCCDACISSYHIHCLNPPLPDIPNGEWLCPRCTCPVLKGRVQKILHWRWGEPPVAVPAPQQADGNPDVPPPRPLQGRSEREFFVKWVGLSYWHCSWAKELQLEIFHLVMYRNYQRKNDMDEPPPLDYGSGEDDGKSDKRKVKDPHYAEMEEKYYRFGIKPEWMTVHRIINHSVDKKGNYHYLVKWRDLPYDQSTWEEDEMNIPEYEEHKQSYWRHRELIMGEDPAQPRKYKKKKKELQGDGPPSSPTNDPTVKYETQPRFITATGGTLHMYQLEGLNWLRFSWAQGTDTILADEMGLGKTIQTIVFLYSLYKEGHTKGPFLVSAPLSTIINWEREFQMWAPKFYVVTYTGDKDSRAIIRENEFSFEDNAIKGGKKAFKMKREAQVKFHVLLTSYELITIDQAALGSIRWACLVVDEAHRLKNNQSKFFRVLNGYKIDHKLLLTGTPLQNNLEELFHLLNFLTPERFNNLEGFLEEFADISKEDQIKKLHDLLGPHMLRRLKADVFKNMPAKTELIVRVELSPMQKKYYKYILTRNFEALNSRGGGNQVSLLNIMMDLKKCCNHPYLFPVAAMESPKLPSGAYEGGALIKSSGKLMLLQKMLRKLKEQGHRVLIFSQMTKMLDLLEDFLDYEGYKYERIDGGITGALRQEAIDRFNAPGAQQFCFLLSTRAGGLGINLATADTVIIFDSDWNPHNDIQAFSRAHRIGQANKVMIYRFVTRASVEERITQVAKRKMMLTHLVVRPGLGSKAGSMSKQELDDILKFGTEELFKDENEGENKEEDSSVIHYDNEAIARLLDRNQDATEDTDVQNMNEYLSSFKVAQYVVREEDKIEEIEREIIKQEENVDPDYWEKLLRHHYEQQQEDLARNLGKGKRVRKQVNYNDAAQEDQDNQSEYSVGSEEEDEDFDERPEGRRQSKRQLRNEKDKPLPPLLARVGGNIEVLGFNTRQRKAFLNAVMRWGMPPQDAFTTQWLVRDLRGKTEKEFKAYVSLFMRHLCEPGADGSETFADGVPREGLSRQQVLTRIGVMSLVKKKVQEFEHINGRWSMPELMPDPSADSKRSSRASSPTKTSPTTPEASATNSPCTSKPATPAPSEKGEGIRTPLEKEEAENQEEKPEKNSRIGEKMETEADAPSPAPSLGERLEPRKIPLEDEVPGVPGEMEPEPGYRGDREKSATESTPGERGEEKPLDGQEHRERPEGETGDLGKREDVKGDRELRPGPRDEPRSNGRREEKTEKPRFMFNIADGGFTELHTLWQNEERAAISSGKLNEIWHRRHDYWLLAGIVLHGYARWQDIQNDAQFAIINEPFKTEANKGNFLEMKNKFLARRFKLLEQALVIEEQLRRAAYLNLSQEPAHPAMALHARFAEAECLAESHQHLSKESLAGNKPANAVLHKVLNQLEELLSDMKADVTRLPATLSRIPPIAARLQMSERSILSRLASKGTEPHPTPAYPPGPYATPPGYGAAFSAAPVGALAAAGANYSQMPAGSFITAATNGPPVLVKKEKEMVGALVSDGLDRKEPRAGEVICIDD
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MKAADTVIL
------CCCCCEEEE
64.6825953088
43PhosphorylationDDIRLLPSALGVKKR
HHCCCCHHHHCCCCC
35.7728509920
48AcetylationLPSALGVKKRKRGPK
CHHHHCCCCCCCCCC
45.0925953088
48UbiquitinationLPSALGVKKRKRGPK
CHHHHCCCCCCCCCC
45.09-
56MethylationKRKRGPKKQKENKPG
CCCCCCCCCCCCCCC
70.50-
58MethylationKRGPKKQKENKPGKP
CCCCCCCCCCCCCCC
72.62-
64MethylationQKENKPGKPRKRKKR
CCCCCCCCCCCCCCC
50.61-
66 (in isoform 3)Phosphorylation-55.7023927012
73PhosphorylationRKRKKRDSEEEFGSE
CCCCCCCCHHHHCCC
51.4423401153
73 (in isoform 2)Phosphorylation-51.44-
79PhosphorylationDSEEEFGSERDEYRE
CCHHHHCCCHHHHHH
34.4823401153
79 (in isoform 2)Phosphorylation-34.48-
84PhosphorylationFGSERDEYREKSESG
HCCCHHHHHHHHHCC
28.5020363803
84 (in isoform 2)Phosphorylation-28.50-
88PhosphorylationRDEYREKSESGGSEY
HHHHHHHHHCCCCCC
32.0425159151
90PhosphorylationEYREKSESGGSEYGT
HHHHHHHCCCCCCCC
56.3923927012
93PhosphorylationEKSESGGSEYGTGPG
HHHHCCCCCCCCCCC
31.0425159151
95PhosphorylationSESGGSEYGTGPGRK
HHCCCCCCCCCCCHH
22.9923663014
97PhosphorylationSGGSEYGTGPGRKRR
CCCCCCCCCCCHHHH
39.0228450419
175AcetylationFMRPLIAKKNPKIPM
HHHHHHHCCCCCCCH
46.2025953088
183PhosphorylationKNPKIPMSKMMTILG
CCCCCCHHHHHHHHH
16.43-
261AcetylationPIRRAKTKEGKGPGH
CCCCCCCCCCCCCCC
64.8655975877
264AcetylationRAKTKEGKGPGHKRR
CCCCCCCCCCCCCCC
64.1255975865
269AcetylationEGKGPGHKRRSKSPR
CCCCCCCCCCCCCCC
56.2655975857
272PhosphorylationGPGHKRRSKSPRVPD
CCCCCCCCCCCCCCC
41.3323403867
274PhosphorylationGHKRRSKSPRVPDGR
CCCCCCCCCCCCCCC
21.1323403867
302AcetylationKLGLLGGKRKKGGSY
EEEECCCCCCCCCCE
60.2825953088
302UbiquitinationKLGLLGGKRKKGGSY
EEEECCCCCCCCCCE
60.28-
308PhosphorylationGKRKKGGSYVFQSDE
CCCCCCCCEEECCCC
27.1326074081
309PhosphorylationKRKKGGSYVFQSDEG
CCCCCCCEEECCCCC
14.4626074081
313PhosphorylationGGSYVFQSDEGPEPE
CCCEEECCCCCCCCC
26.6030576142
324PhosphorylationPEPEAEESDLDSGSV
CCCCCCCCCCCCCCC
34.6723401153
324 (in isoform 2)Phosphorylation-34.67-
328PhosphorylationAEESDLDSGSVHSAS
CCCCCCCCCCCCCCC
40.0222167270
330PhosphorylationESDLDSGSVHSASGR
CCCCCCCCCCCCCCC
22.1722167270
333PhosphorylationLDSGSVHSASGRPDG
CCCCCCCCCCCCCCC
23.2121955146
335PhosphorylationSGSVHSASGRPDGPV
CCCCCCCCCCCCCCC
38.0530576142
374PhosphorylationGEEEVDGYETDHQDY
CCCCCCCCCCCCHHH
15.9327251275
376PhosphorylationEEVDGYETDHQDYCE
CCCCCCCCCCHHHHH
30.2330576142
381PhosphorylationYETDHQDYCEVCQQG
CCCCCHHHHHHHHCC
5.5025849741
506UbiquitinationRCTCPVLKGRVQKIL
CCCCHHHCCCHHHHH
44.92-
578PhosphorylationEIFHLVMYRNYQRKN
HHHHHHHHHCCCCCC
6.5520068231
595PhosphorylationDEPPPLDYGSGEDDG
CCCCCCCCCCCCCCC
22.3723927012
597PhosphorylationPPPLDYGSGEDDGKS
CCCCCCCCCCCCCCC
32.5522167270
597 (in isoform 2)Phosphorylation-32.55-
604PhosphorylationSGEDDGKSDKRKVKD
CCCCCCCCCCCCCCC
54.6223403867
620UbiquitinationHYAEMEEKYYRFGIK
CHHHHHHHHHHCCCC
33.99-
627SumoylationKYYRFGIKPEWMTVH
HHHHCCCCCCHHHHH
36.95-
627SumoylationKYYRFGIKPEWMTVH
HHHHCCCCCCHHHHH
36.9528112733
640PhosphorylationVHRIINHSVDKKGNY
HHHHHCCCCCCCCCE
27.76-
644UbiquitinationINHSVDKKGNYHYLV
HCCCCCCCCCEEEEE
48.18-
652UbiquitinationGNYHYLVKWRDLPYD
CCEEEEEEECCCCCC
33.64-
712PhosphorylationLQGDGPPSSPTNDPT
HCCCCCCCCCCCCCC
52.6729255136
712 (in isoform 2)Phosphorylation-52.67-
713PhosphorylationQGDGPPSSPTNDPTV
CCCCCCCCCCCCCCC
41.3329255136
713 (in isoform 2)Phosphorylation-41.33-
715PhosphorylationDGPPSSPTNDPTVKY
CCCCCCCCCCCCCCC
54.9530266825
715 (in isoform 2)Phosphorylation-54.95-
719PhosphorylationSSPTNDPTVKYETQP
CCCCCCCCCCCCCCC
32.2822167270
721SumoylationPTNDPTVKYETQPRF
CCCCCCCCCCCCCEE
39.5925114211
721UbiquitinationPTNDPTVKYETQPRF
CCCCCCCCCCCCCEE
39.59-
722PhosphorylationTNDPTVKYETQPRFI
CCCCCCCCCCCCEEE
21.6324732914
724PhosphorylationDPTVKYETQPRFITA
CCCCCCCCCCEEEEE
40.5624732914
739PhosphorylationTGGTLHMYQLEGLNW
CCCEEEEEEECCCCC
10.13-
777PhosphorylationQTIVFLYSLYKEGHT
HHHHHHHHHHHCCCC
27.6324719451
820AcetylationVVTYTGDKDSRAIIR
EEEEECCCCCCEEEE
59.9726051181
820UbiquitinationVVTYTGDKDSRAIIR
EEEEECCCCCCEEEE
59.97-
832PhosphorylationIIRENEFSFEDNAIK
EEECCCCCCCCCCCC
22.8820873877
839UbiquitinationSFEDNAIKGGKKAFK
CCCCCCCCCCHHHHH
60.23-
860PhosphorylationVKFHVLLTSYELITI
HHHEEEECEEEEEEE
25.7120068231
860 (in isoform 2)Phosphorylation-25.71-
861PhosphorylationKFHVLLTSYELITID
HHEEEECEEEEEEEC
19.3123403867
861 (in isoform 2)Phosphorylation-19.31-
862PhosphorylationFHVLLTSYELITIDQ
HEEEECEEEEEEECH
14.9823403867
866PhosphorylationLTSYELITIDQAALG
ECEEEEEEECHHHHH
31.0023403867
866 (in isoform 2)Phosphorylation-31.00-
874PhosphorylationIDQAALGSIRWACLV
ECHHHHHCCHHHHHH
15.1620068231
874 (in isoform 2)Phosphorylation-15.16-
894AcetylationRLKNNQSKFFRVLNG
HHHCCCCHHHHHHCC
38.4619608861
894UbiquitinationRLKNNQSKFFRVLNG
HHHCCCCHHHHHHCC
38.46-
954UbiquitinationISKEDQIKKLHDLLG
CCHHHHHHHHHHHHC
43.58-
969AcetylationPHMLRRLKADVFKNM
HHHHHHHHCHHHCCC
40.5027452117
969UbiquitinationPHMLRRLKADVFKNM
HHHHHHHHCHHHCCC
40.50-
974UbiquitinationRLKADVFKNMPAKTE
HHHCHHHCCCCCCEE
52.78-
979UbiquitinationVFKNMPAKTELIVRV
HHCCCCCCEEEEEEE
36.34-
989PhosphorylationLIVRVELSPMQKKYY
EEEEEEECHHHHHHH
12.5724719451
991SulfoxidationVRVELSPMQKKYYKY
EEEEECHHHHHHHHH
9.0721406390
993AcetylationVELSPMQKKYYKYIL
EEECHHHHHHHHHHH
36.1725953088
997AcetylationPMQKKYYKYILTRNF
HHHHHHHHHHHHHCH
23.7919608861
997UbiquitinationPMQKKYYKYILTRNF
HHHHHHHHHHHHHCH
23.79-
997 (in isoform 1)Ubiquitination-23.7921890473
997 (in isoform 2)Ubiquitination-23.7921890473
998PhosphorylationMQKKYYKYILTRNFE
HHHHHHHHHHHHCHH
5.76-
1001PhosphorylationKYYKYILTRNFEALN
HHHHHHHHHCHHHHH
17.63-
1044UbiquitinationVAAMESPKLPSGAYE
HHHCCCCCCCCCCCC
80.47-
1047PhosphorylationMESPKLPSGAYEGGA
CCCCCCCCCCCCCCE
46.6324719451
1050PhosphorylationPKLPSGAYEGGALIK
CCCCCCCCCCCEEEH
20.7324719451
1057UbiquitinationYEGGALIKSSGKLML
CCCCEEEHHCHHHHH
39.14-
1059PhosphorylationGGALIKSSGKLMLLQ
CCEEEHHCHHHHHHH
34.6424719451
1067UbiquitinationGKLMLLQKMLRKLKE
HHHHHHHHHHHHHHH
39.61-
1083PhosphorylationGHRVLIFSQMTKMLD
CCCEEEEHHHHHHHH
16.4324719451
1086PhosphorylationVLIFSQMTKMLDLLE
EEEEHHHHHHHHHHH
12.9827251275
1103PhosphorylationLDYEGYKYERIDGGI
HCCCCCCEEEECCCC
11.2722817900
1205PhosphorylationAKRKMMLTHLVVRPG
HHHHHHHHHHHHCCC
8.68-
1219PhosphorylationGLGSKAGSMSKQELD
CCCCCCCCCCHHHHH
25.41-
1222AcetylationSKAGSMSKQELDDIL
CCCCCCCHHHHHHHH
38.8720167786
1222UbiquitinationSKAGSMSKQELDDIL
CCCCCCCHHHHHHHH
38.87-
1230UbiquitinationQELDDILKFGTEELF
HHHHHHHHHCHHHHH
41.92-
1238SumoylationFGTEELFKDENEGEN
HCHHHHHCCCCCCCC
76.41-
1238SumoylationFGTEELFKDENEGEN
HCHHHHHCCCCCCCC
76.41-
1238UbiquitinationFGTEELFKDENEGEN
HCHHHHHCCCCCCCC
76.41-
1246UbiquitinationDENEGENKEEDSSVI
CCCCCCCCCCCCCCE
59.17-
1251PhosphorylationENKEEDSSVIHYDNE
CCCCCCCCCEEECHH
37.1025849741
1274PhosphorylationNQDATEDTDVQNMNE
CCCCCCCCCCCHHHH
31.66-
1282PhosphorylationDVQNMNEYLSSFKVA
CCCHHHHHHHHHHHH
13.59-
1284PhosphorylationQNMNEYLSSFKVAQY
CHHHHHHHHHHHHHH
32.59-
1285PhosphorylationNMNEYLSSFKVAQYV
HHHHHHHHHHHHHHH
26.87-
1287UbiquitinationNEYLSSFKVAQYVVR
HHHHHHHHHHHHHHC
38.31-
1298UbiquitinationYVVREEDKIEEIERE
HHHCCHHHHHHHHHH
56.12-
1308SumoylationEIEREIIKQEENVDP
HHHHHHHHCHHCCCH
58.27-
1308SumoylationEIEREIIKQEENVDP
HHHHHHHHCHHCCCH
58.2728112733
1308UbiquitinationEIEREIIKQEENVDP
HHHHHHHHCHHCCCH
58.27-
1317PhosphorylationEENVDPDYWEKLLRH
HHCCCHHHHHHHHHH
22.36-
1320UbiquitinationVDPDYWEKLLRHHYE
CCHHHHHHHHHHHHH
38.38-
1323MethylationDYWEKLLRHHYEQQQ
HHHHHHHHHHHHHHH
25.60-
1339UbiquitinationDLARNLGKGKRVRKQ
HHHHHCCCCHHHHHH
65.51-
1349PhosphorylationRVRKQVNYNDAAQED
HHHHHCCCCCHHHHC
18.6322115753
1361PhosphorylationQEDQDNQSEYSVGSE
HHCCCCCCCCCCCCH
44.7722115753
1361 (in isoform 2)Phosphorylation-44.77-
1363PhosphorylationDQDNQSEYSVGSEEE
CCCCCCCCCCCCHHC
17.5728450419
1364PhosphorylationQDNQSEYSVGSEEED
CCCCCCCCCCCHHCC
18.8922617229
1364 (in isoform 2)Phosphorylation-18.89-
1367PhosphorylationQSEYSVGSEEEDEDF
CCCCCCCCHHCCCCC
39.4122617229
1367 (in isoform 2)Phosphorylation-39.41-
1394SumoylationQLRNEKDKPLPPLLA
HHHHCCCCCCCHHHH
60.57-
1394SumoylationQLRNEKDKPLPPLLA
HHHHCCCCCCCHHHH
60.57-
1394UbiquitinationQLRNEKDKPLPPLLA
HHHHCCCCCCCHHHH
60.57-
1436PhosphorylationMPPQDAFTTQWLVRD
CCHHHHHHHHHHHHH
21.5729083192
1437PhosphorylationPPQDAFTTQWLVRDL
CHHHHHHHHHHHHHH
15.9929083192
1522PhosphorylationPELMPDPSADSKRSS
CHHCCCCCCCCCCCC
52.6826074081
1525PhosphorylationMPDPSADSKRSSRAS
CCCCCCCCCCCCCCC
29.6826074081
1528O-linked_GlycosylationPSADSKRSSRASSPT
CCCCCCCCCCCCCCC
28.1029351928
1528PhosphorylationPSADSKRSSRASSPT
CCCCCCCCCCCCCCC
28.1029514088
1529PhosphorylationSADSKRSSRASSPTK
CCCCCCCCCCCCCCC
35.5830576142
1532PhosphorylationSKRSSRASSPTKTSP
CCCCCCCCCCCCCCC
35.4229116813
1533PhosphorylationKRSSRASSPTKTSPT
CCCCCCCCCCCCCCC
35.2930576142
1535PhosphorylationSSRASSPTKTSPTTP
CCCCCCCCCCCCCCC
49.2329116813
1536UbiquitinationSRASSPTKTSPTTPE
CCCCCCCCCCCCCCC
50.84-
1536 (in isoform 1)Ubiquitination-50.8421890473
1536 (in isoform 2)Ubiquitination-50.8421890473
1537PhosphorylationRASSPTKTSPTTPEA
CCCCCCCCCCCCCCC
42.2830266825
1538PhosphorylationASSPTKTSPTTPEAS
CCCCCCCCCCCCCCC
23.0830266825
1540PhosphorylationSPTKTSPTTPEASAT
CCCCCCCCCCCCCCC
55.5430266825
1541PhosphorylationPTKTSPTTPEASATN
CCCCCCCCCCCCCCC
23.6323401153
1545PhosphorylationSPTTPEASATNSPCT
CCCCCCCCCCCCCCC
33.6823401153
1547PhosphorylationTTPEASATNSPCTSK
CCCCCCCCCCCCCCC
33.4623401153
1549PhosphorylationPEASATNSPCTSKPA
CCCCCCCCCCCCCCC
19.5930266825
1549 (in isoform 2)Phosphorylation-19.59-
1552PhosphorylationSATNSPCTSKPATPA
CCCCCCCCCCCCCCC
43.0730266825
1553PhosphorylationATNSPCTSKPATPAP
CCCCCCCCCCCCCCC
43.2730266825
1554AcetylationTNSPCTSKPATPAPS
CCCCCCCCCCCCCCC
22.1026051181
1554UbiquitinationTNSPCTSKPATPAPS
CCCCCCCCCCCCCCC
22.10-
1554 (in isoform 1)Ubiquitination-22.1021890473
1554 (in isoform 2)Ubiquitination-22.1021890473
1557PhosphorylationPCTSKPATPAPSEKG
CCCCCCCCCCCCCCC
28.6330266825
1561PhosphorylationKPATPAPSEKGEGIR
CCCCCCCCCCCCCCC
54.7923927012
1569PhosphorylationEKGEGIRTPLEKEEA
CCCCCCCCCHHHHHH
30.2423898821
1569 (in isoform 2)Phosphorylation-30.24-
1573AcetylationGIRTPLEKEEAENQE
CCCCCHHHHHHHCHH
69.4126051181
1587PhosphorylationEEKPEKNSRIGEKME
HCCCCHHCCHHHHHH
36.0222817900
1592AcetylationKNSRIGEKMETEADA
HHCCHHHHHHCCCCC
36.5026051181
1595PhosphorylationRIGEKMETEADAPSP
CHHHHHHCCCCCCCC
32.7323927012
1601PhosphorylationETEADAPSPAPSLGE
HCCCCCCCCCCCHHH
35.1029255136
1601 (in isoform 2)Phosphorylation-35.10-
1605PhosphorylationDAPSPAPSLGERLEP
CCCCCCCCHHHCCCC
51.6329255136
1605 (in isoform 2)Phosphorylation-51.63-
1634PhosphorylationEMEPEPGYRGDREKS
CCCCCCCCCCCCCCC
23.3426552605
1641PhosphorylationYRGDREKSATESTPG
CCCCCCCCCCCCCCC
35.3529396449
1643PhosphorylationGDREKSATESTPGER
CCCCCCCCCCCCCCC
37.2429396449
1645PhosphorylationREKSATESTPGERGE
CCCCCCCCCCCCCCC
35.2329396449
1646PhosphorylationEKSATESTPGERGEE
CCCCCCCCCCCCCCC
29.1326055452
1674AcetylationGETGDLGKREDVKGD
CCCCCCCCCCCCCCC
60.9725953088
1759MethylationIVLHGYARWQDIQND
HHHHCHHCHHHHCCC
24.09-
1782UbiquitinationPFKTEANKGNFLEMK
CCCCCCCCCCHHHHH
63.38-
1815PhosphorylationEQLRRAAYLNLSQEP
HHHHHHHHCCCCCCC
8.6421406692
1819PhosphorylationRAAYLNLSQEPAHPA
HHHHCCCCCCCCCHH
31.2721406692
1842PhosphorylationEAECLAESHQHLSKE
HHHHHHHHHHHHCHH
23.8821406692
1847PhosphorylationAESHQHLSKESLAGN
HHHHHHHCHHHHCCC
32.0521406692
1848UbiquitinationESHQHLSKESLAGNK
HHHHHHCHHHHCCCC
58.65-
1850PhosphorylationHQHLSKESLAGNKPA
HHHHCHHHHCCCCCH
27.53-
1855UbiquitinationKESLAGNKPANAVLH
HHHHCCCCCHHHHHH
44.59-
1873PhosphorylationNQLEELLSDMKADVT
HHHHHHHHHCCCCHH
48.5624719451
1876UbiquitinationEELLSDMKADVTRLP
HHHHHHCCCCHHHCC
46.56-
1880PhosphorylationSDMKADVTRLPATLS
HHCCCCHHHCCHHHH
27.3424719451
1899PhosphorylationIAARLQMSERSILSR
HHHHHHCCHHHHHHH
19.5224719451
1902PhosphorylationRLQMSERSILSRLAS
HHHCCHHHHHHHHHH
24.6724719451
1905PhosphorylationMSERSILSRLASKGT
CCHHHHHHHHHHCCC
24.4724719451
1982PhosphorylationEMVGALVSDGLDRKE
HHHHHHHCCCCCCCC
27.1529083192
1988SumoylationVSDGLDRKEPRAGEV
HCCCCCCCCCCCCCE
72.2728112733

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of CHD3_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
1971KSumoylation

27068747

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CHD3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PAIRB_HUMANSERBP1physical
12505151
HABP4_HUMANHABP4physical
12505151
HDAC1_HUMANHDAC1physical
9804427
HDAC2_HUMANHDAC2physical
9804427
P53_HUMANTP53physical
10961991
P73_HUMANTP73physical
10961991
SUMO1_HUMANSUMO1physical
10961991
MIC60_HUMANIMMTphysical
16169070
BCL6_HUMANBCL6physical
15454082
HDAC2_HUMANHDAC2physical
17827154
HDAC1_HUMANHDAC1physical
17827154
CSK21_HUMANCSNK2A1physical
17827154
PCNT_HUMANPCNTphysical
17626165
MYB_HUMANMYBphysical
17344210
DDX5_HUMANDDX5physical
20676135
HDAC1_HUMANHDAC1physical
9885572
CHD4_HUMANCHD4physical
9885572
CHD3_HUMANCHD3physical
9885572
HDAC2_HUMANHDAC2physical
9885572
RBBP4_HUMANRBBP4physical
9885572
MTA1_HUMANMTA1physical
9885572
TIF1B_HUMANTRIM28physical
21642969
SUMO1_HUMANSUMO1physical
21642969
TWST1_HUMANTWIST1physical
22457607
HD_HUMANHTTphysical
15383276
GIT1_HUMANGIT1physical
15383276
PR40A_HUMANPRPF40Aphysical
15383276
SUMO2_HUMANSUMO2physical
15383276
VIME_HUMANVIMphysical
15383276
CHD3_HUMANCHD3physical
15383276
LRIF1_HUMANLRIF1physical
15383276
PIAS4_HUMANPIAS4physical
15383276
ZHX1_HUMANZHX1physical
15383276
NFL_HUMANNEFLphysical
15383276
TCRG1_HUMANTCERG1physical
15383276
P53_HUMANTP53physical
15383276
PTN_HUMANPTNphysical
15383276
IMB1_HUMANKPNB1physical
15383276
TAL1_HUMANTAL1physical
15383276
MIC60_HUMANIMMTphysical
15383276
IKZF1_HUMANIKZF1physical
10204490
MTA2_HUMANMTA2physical
22939629
MBD3_HUMANMBD3physical
22939629
HDAC2_HUMANHDAC2physical
22939629
HDAC1_HUMANHDAC1physical
22939629
RBBP7_HUMANRBBP7physical
22939629
CHD4_HUMANCHD4physical
22939629
RBBP4_HUMANRBBP4physical
22939629
P66A_HUMANGATAD2Aphysical
22939629
SMRC2_HUMANSMARCC2physical
22939629
HDAC3_HUMANHDAC3physical
22939629
TIF1B_HUMANTRIM28physical
24018422
SUMO2_HUMANSUMO2physical
24018422
CD2B2_HUMANCD2BP2physical
26344197
CPSF1_HUMANCPSF1physical
26344197
MAP2_HUMANMETAP2physical
26344197
MTA1_HUMANMTA1physical
26344197
MTA2_HUMANMTA2physical
26344197
MTA3_HUMANMTA3physical
26344197
H31_HUMANHIST1H3Aphysical
25533843
H2B1B_HUMANHIST1H2BBphysical
25533843

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CHD3_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-713; SER-1601 ANDSER-1605, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-713; SER-1549; SER-1601AND SER-1605, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-713; SER-1361; SER-1364;SER-1367; SER-1601 AND SER-1605, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-713 AND SER-1601, ANDMASS SPECTROMETRY.
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-43, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-324; SER-713; SER-1601AND SER-1605, AND MASS SPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-713 AND SER-1601, ANDMASS SPECTROMETRY.

TOP